Product Profiles

Article

Product Profiles

Preservative-free drops

Taflotan, developed by Santen, is a preservativefree prostglandin eye drop tailored for glaucoma patients. The drops provide an alternative treatment for lowering intraocular pressure.

The eye drops are an ideal solution for patients who experience side effects from glaucoma eye drops with preservatives. Taflotan is also well-suited for dry and sensitive eyes.

DMEK instrument set

Geuder's Descemet Membrane Endothelial Keratoplasty (DMEK) instrument set is ideal to use when performing posterior lamellar keratoplasty.

The set includes the SZURMAN DMEK cartridge. This enables touch-free and friction-free handling of the donor tissue.

The cartridge allows the smooth and controlled implantation of the donor tissue into the patient's anterior chamber. The cartridge is slender; meaning it only needs a 3.0 mm clear cornea incision. The DMEK procedure can be performed without subsequent suturing.

As well as the sterile SZURMAN implantation cartridge, the DMEK set includes instruments for preparing donor tissue, preparing the patient's eye and the implantation of donor tissue.

Pattern-scanning laser

Topcon Medical Laser Systems has launched the PASCAL Streamline 577 laser. The trueyellow 577 nm wavelength system is a pattern-scanning laser for treating anterior and posterior ophthalmic disorders.

The laser system is able to treat glaucoma, diabetic retinopathy, wet age-related macular degeneration and retinal vascular occlusive disease.

The Streamline 577 system enables surgeons to conduct procedures efficiently and with more control. Laser parameters can be finely tuned, meaning patient comfort is significantly improved.

The system causes less trauma and more control over laser output due to the wavelength being 'macular friendly'. It is possible to print procedure summaries with PASCAL Streamline 577, as well as using the onboard Video Teaching System (VTS). The VTS comes complete with an integrated video camera and monitor.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.